XVC-12871-14651

2 vaccinations 7 coded responses 12 check-ins 7 free-text entries 6 call cases

Sex: Female
Age at first dose: 41-45
ZIP prefix: 983 / WA
Registered: 2020-12-14

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-14
Registered in v-safe
2020-12-17
Dose 1 — Pfizer-BioNTech
2021-01-06
Dose 2 — Pfizer-BioNTech
2021-01-08
Survey response — days 1–6 daily, dose 2
MedDRA: Axillary mass — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to work, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-01-08
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Get care from a doctor or other healthcare professional

1 call case(s)
2021-01-09
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site

Adult check-in
2021-01-10
Survey response — days 1–6 daily, dose 2
MedDRA: Axillary mass, Pharyngeal swelling, Reaction to previous exposure to any vaccine, Urticaria — Feeling: Good · Rash, not including the immediate area around the injection site

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-01-11
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site

Adult check-in
2021-01-21
Health check-in — 14 day, dose 2
Feeling: Good

Adult check-in
2021-01-27
Health check-in — 21 day, dose 2
Feeling: Good

Adult check-in
2021-02-05
Survey response — 28 day, dose 2
MedDRA: Urticaria — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-02-05
Report sent to call center — 28 day, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-11
Survey response — 35 day, dose 2
MedDRA: Urticaria — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-02-11
Report sent to call center — 35 day, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-15
Call 1 — Could Not Reach Participant
2021-02-18
Health check-in — 42 day, dose 2
Feeling: Good

Adult check-in
2021-02-19
Call 2 — Could Not Reach Participant
2021-02-24
Call 3 — Could Not Reach Participant
2021-04-07
Survey response — 3 month, dose 2
MedDRA: Condition aggravated, Urticaria — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-04-07
Report sent to call center — 3 month, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-15
Call 1 — Left Voicemail
2021-07-07
Survey response — 6 month, dose 2
MedDRA: Migraine — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-07-07
Report sent to call center — 6 month, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-07-15
Call 1 — Left Voicemail
2021-08-12
Call successful
Participant prefers to complete VAERS report online
2022-01-06
Survey response — 12 month, dose 2
MedDRA: Asthenia, Myalgia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

MedDRA releases: 2024-11 · check-in answers available
2022-01-06
Report sent to call center — 12 month, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-01-10
Call 1 — Left Voicemail
2022-01-21
Call 2 — Could Not Reach Participant

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-17	Pfizer-BioNTech
2	2021-01-06	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-08	Successful	Participant prefers to complete VAERS report online
2021-02-05	Successful	Participant prefers to complete VAERS report online
2021-02-11	Successful	Participant prefers to complete VAERS report online
2021-04-07	Successful	Participant prefers to complete VAERS report online
2021-07-07	Successful 2021-08-12	Participant prefers to complete VAERS report online
2022-01-06	Unsuccessful

Free text

Release 1

Systemic reaction (other): Lump in armpit on side of injection site

Systemic reaction (other): The day of the injection, i had mild swelling of my throat. The next day, i developed a large lump under my left armpit that is still there but smaller now that im on prednisone. I developed hives a week after the first injection that worsened after the second injection. I didn't have this app at that time, but can someone give me a call please?

Release 3

Symptoms: Worsening hives

Release 4

Symptoms: Hives

Release 7

Symptoms: Worsening hives

Release 9

Symptoms: Migraines

Release 10

Symptoms: Severe widespread muscle pain and weakness

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Asthenia	·	·	✓
SD	Condition aggravated	✓	✓	✓
SD	Migraine	✓	✓	✓
SD	Myalgia	·	·	✓
SD	Urticaria	✓	✓	✓
SRO	Axillary mass	✓	✓	✓
SRO	Lymphadenopathy	○	○	○
SRO	Pharyngeal swelling	✓	✓	✓
SRO	Reaction to previous exposure to any vaccine	✓	✓	✓
SRO	Urticaria	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release